Patents Assigned to Apytinyx Inc.
  • Spiro-lactam NMDA receptor modulators and uses thereof
    Patent number: 9708335
    Abstract: Disclosed are compounds having enhanced potency in the modulation of NMDA receptor activity. Such compounds are contemplated for use in the treatment of conditions such as depression and related disorders. Orally available formulations and other pharmaceutically acceptable delivery forms of the compounds, including intravenous formulations, are also disclosed.
    Type: Grant
    Filed: January 29, 2014
    Date of Patent: July 18, 2017
    Assignee: Apytinyx Inc.
    Inventors: John A. Lowe, III, M. Amin Khan